Form 4: Director's Options Cancelled Post-Generation Bio Merger

A Form 4 filing reveals Generation Bio Co. director Jeffrey M. Jonas's stock options were cancelled following the company's merger with XOMA Royalty Corporation.

Summary

• Generation Bio Co. merged with XRA 7 Corp., a wholly-owned subsidiary of XOMA Royalty Corporation, effective February 9, 2026.
• Generation Bio Co. is now a wholly-owned subsidiary of XOMA Royalty Corporation.
• Director Jeffrey M. Jonas's stock options were affected by the merger terms.
• Options with an exercise price below $4.2913 (Cash Amount) were converted into a cash payment.
• Options with an exercise price equal to or above $4.2913 were cancelled for no consideration.
• Jeffrey M. Jonas had one option for 3,000 shares at $3.874 converted to cash.
• Jeffrey M. Jonas had options for 21,366 shares with higher exercise prices cancelled for no consideration.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development for the reporting person's equity holdings, as a substantial number of options were cancelled without value, indicating a low merger premium relative to historical option grants.

Positives

• The reporting person received a cash payout for one in-the-money stock option, indicating some value realization for that specific grant.

Negatives

• A significant number of the reporting person's stock options (21,366 shares) were cancelled for no consideration due to their exercise price being at or above the merger's Cash Amount of $4.2913.
• The merger resulted in Generation Bio Co. becoming a wholly-owned subsidiary, implying a loss of independent public trading status for its common stock.

Future Outlook

The filing does not contain specific forward-looking statements or guidance, as it primarily reports on past transactions related to a merger.

Industry Context

StockSavvy.ai notes that mergers and acquisitions are common drivers for changes in executive and director compensation structures, particularly regarding equity awards. The cancellation of out-of-the-money options is a standard outcome in such transactions when the acquisition price does not exceed the strike price of those options, reflecting the market value at the time of the merger.

Stakeholder Impact

• Shareholders: Existing shareholders of Generation Bio Co. would have received the Cash Amount of $4.2913 per share, as the company became a wholly-owned subsidiary.
• Option Holders: Option holders whose exercise price was below $4.2913 received a cash payout, while those with higher exercise prices had their options cancelled for no consideration.

Key Dates

Keywords

Generation Bio Co., GBIO, XOMA Royalty Corporation, Merger, Stock Options, Form 4, Insider Transaction, Beneficial Ownership, Jeffrey M Jonas, Corporate Action